Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved

Assunta Bianco, Paolo Maria Rossini, Massimiliano Mirabella

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

No abstract available
Original languageEnglish
Pages (from-to)924-925
Number of pages2
JournalJAMA Neurology
Volume71
DOIs
Publication statusPublished - 2014

Keywords

  • Antibodies, Monoclonal, Humanized
  • Drug Substitution
  • Female
  • Humans
  • Immunosuppressive Agents
  • Male
  • Multiple Sclerosis
  • Propylene Glycols
  • Sphingosine

Fingerprint

Dive into the research topics of 'Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved'. Together they form a unique fingerprint.

Cite this